Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
NYC facility halves UTI rate, care costs with ‘practical’ intervention
By
Alicia Lasek
Mar 15, 2021
Gouverneur Health, a 295-bed skilled nursing facility, brought its average UTI rate to 2.13%, — lower than state and national benchmarks — and reduced its related care costs by 52% from the pre-intervention...
Clinical briefs for Wednesday, March 3
By
Alicia Lasek
Mar 03, 2021
Senior living chief medical officer reflects on COVID a year into pandemic, including vaccine acceptance … NIH halts convalescent plasma trial in ED patients with mild COVID symptoms … Stroke patients...
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
Clinical briefs for Wednesday, Feb. 10
By
Alicia Lasek
Feb 10, 2021
Establish skeletal age to predict patient’s fracture risk, researchers say … Pandemic has ‘profoundly affected’ osteoporosis care, survey shows … NYC nursing home gave residents hydroxychloroquine...
Ford’s clear N95 face mask a game changer for healthcare, hearing impaired, company claims
By
Alicia Lasek
Feb 05, 2021
Ford Motor Co. is seeking an N95 designation for its clear respirator design. The product is expected to become available this spring if approved, the company announced Tuesday.
NIH: Inhaled moisturizing drug boosts lung function in severe COPD
By
Alicia Lasek
Feb 02, 2021
The biologic drug hyaluronan improved lung function in patients hospitalized for severe exacerbation of chronic obstructive pulmonary disease, a new study finds.
Clinical briefs for Thursday, Jan. 28
By
Amy Novotney
Jan 28, 2021
Americans’ reluctance to get vaccinated for COVID-19 is waning, new poll finds … Walgreens plans to complete administration of COVID-19 first doses in assisted living facilities by mid-February …...
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
Clinical briefs for Thursday, Jan. 21
By
Alicia Lasek
Jan 20, 2021
Vaccine successes: LTC advocates share effective tools to increase inoculation confidence among staff … More evidence shows Pfizer vaccine protects against UK virus strain … Pennsylvania launches retail...